New cancer clinical trial: EOC202 Plus First-line Paclitaxel Phase Ⅰ Trail in Chinese Patients With Metastatic Breast Cancer

Published on: July 25, 2018 at 12:00PM
Condition:   Solid Tumor, Adult
Interventions:   Biological: EOC202;   Drug: Paclitaxel
Sponsor:   EddingPharm Oncology Co., LTD.
Not yet recruiting
https://ift.tt/2mPATBH